Please login to the form below

Not currently logged in

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

Bluebird Bio

First patient is likely to be treated later in the year due to pandemic

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

Fallout from pandemic continues to affect business in myriad ways

Novartis forms coronavirus alliance with life sciences companies

Novartis buildingPartnership will accelerate research with aid of Gates Foundation

Gilead halts individual requests for COVID-19 hopeful remdesivir

GileadWill now focus on expanded access programmes and backlog

WHO partners with WhatsApp to provide accurate COVID-19 information

WHOSocial media platform will provide users with facts around virus

Bayer signs €250m pact with India’s Curadev for STING drugs

Bayer symbolResearch will focus on auto-immune and inflammatory diseases

Biogen joins COVID-19 efforts with $10m support fund

BiogenFunds will be used to address 'immediate critical needs'

Lilly joins new Medicare scheme to reduce insulin prices

Eli Lilly new HQNew model will cover seniors enrolled in Medicare Part D

AXON recognised for ‘excellence in wellbeing’ by Great Place to Work

AXON team picHealthcare comms company wins recognition for second year in a row

Digital medcommsCurrent and future trends for developing digital medical communications

Evolving digital trends and user needs

COVID-19 Updates and Daily News

Featured jobs


Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...